SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
08-Aug-24 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Aug-24 | Private Sale (Planned) | 2,280 | $476.75 | $1,086,990.00 | (9%) 25.54K to 23.26K | |
25-Jul-24 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Jul-24 | Private Sale (Planned) | 2,280 | $488.46 | $1,113,690.00 | (8%) 27.82K to 25.54K | |
12-Jul-24 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Jul-24 | Private Sale (Planned) | 2,280 | $487.34 | $1,111,140.00 | (8%) 30.1K to 27.82K | |
28-Jun-24 4:04 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Jun-24 | Private Sale (Planned) | 2,280 | $471.72 | $1,075,520.00 | (7%) 32.38K to 30.1K | |
13-Jun-24 4:11 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Jun-24 | Private Sale (Planned) | 2,280 | $478.00 | $1,089,840.00 | (7%) 34.66K to 32.38K | |
31-May-24 4:19 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-May-24 | Private Sale (Planned) | 2,280 | $445.56 | $1,015,880.00 | (6%) 36.94K to 34.66K | |
27-Feb-24 4:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 3,309 | $431.79 | $1,428,790.00 | (8%) 40.25K to 36.94K | |
21-Feb-24 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 2,812 | $420.58 | $1,182,670.00 | (7%) 43.06K to 40.25K | |
21-Feb-24 4:26 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 3,750 | $424.01 | $1,590,040.00 | (8%) 46.81K to 43.06K | |
13-Feb-24 5:01 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 2,100 | $422.74 | $887,754.00 | (4%) 48.91K to 46.81K | |
08-Feb-24 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 5,928 | -- | -- | 14% 42.98K to 48.91K | |
08-Feb-24 4:33 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 13,680 | -- | -- | 47% 29.3K to 42.98K | |
16-Nov-23 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-Nov-23 | Private Sale (Planned) | 5,650 | $380.82 | $2,151,630.00 | (16%) 34.95K to 29.3K | |
02-Nov-23 4:07 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-Oct-23 | Private Sale (Planned) | 5,651 | $355.92 | $2,011,300.00 | (14%) 40.6K to 34.95K | |
19-Oct-23 4:18 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Oct-23 | Private Sale (Planned) | 5,651 | $373.25 | $2,109,240.00 | (12%) 46.25K to 40.6K | |
05-Oct-23 4:30 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Oct-23 | Private Sale (Planned) | 5,651 | $345.28 | $1,951,180.00 | (11%) 51.91K to 46.25K | |
21-Sep-23 4:15 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 19-Sep-23 | Private Sale (Planned) | 5,651 | $351.00 | $1,983,500.00 | (10%) 57.56K to 51.91K | |
07-Sep-23 4:29 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Sep-23 | Private Sale (Planned) | 5,651 | $352.66 | $1,992,880.00 | (9%) 63.21K to 57.56K | |
28-Feb-23 4:50 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-23 | Payment of Exercise | 3,308 | $289.12 | $956,409.00 | (5%) 66.52K to 63.21K | |
22-Feb-23 4:32 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-23 | Payment of Exercise | 3,750 | $292.85 | $1,098,190.00 | (5%) 70.27K to 66.52K | |
14-Feb-23 4:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 13-Feb-23 | Payment of Exercise | 4,992 | $298.26 | $1,488,910.00 | (7%) 75.26K to 70.27K | |
14-Feb-23 4:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-23 | Payment of Exercise | 2,707 | $294.33 | $796,751.00 | (3%) 77.96K to 75.26K | |
03-Feb-23 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-23 | Grant | 28,452 | -- | -- | 57% 49.51K to 77.96K | |
02-Jun-22 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 31-May-22 | Payment of Exercise | 311 | $271.24 | $84,355.60 | (< 1%) 49.82K to 49.51K | |
28-Feb-22 5:20 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-22 | Payment of Exercise | 1,242 | $227.86 | $283,002.00 | (2%) 51.06K to 49.82K | |
22-Feb-22 4:55 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 17-Feb-22 | Payment of Exercise | 3,439 | $232.51 | $799,602.00 | (6%) 54.5K to 51.06K | |
14-Feb-22 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-22 | Payment of Exercise | 2,437 | $237.74 | $579,372.00 | (4%) 56.94K to 54.5K | |
03-Feb-22 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 01-Feb-22 | Grant | 23,988 | -- | -- | 73% 32.95K to 56.94K | |
02-Jun-21 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 28-May-21 | Payment of Exercise | 311 | $210.04 | $65,322.40 | (< 1%) 33.26K to 32.95K | |
26-Feb-21 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-21 | Payment of Exercise | 311 | $217.57 | $67,664.30 | (< 1%) 33.58K to 33.26K | |
12-Feb-21 4:06 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 10-Feb-21 | Payment of Exercise | 2,367 | $214.16 | $506,917.00 | (7%) 35.94K to 33.58K | |
05-Feb-21 4:45 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 03-Feb-21 | Grant | 21,951 | -- | -- | 157% 13.99K to 35.94K | |
02-Jun-20 4:14 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 29-May-20 | Payment of Exercise | 311 | $282.74 | $87,932.10 | (2%) 14.3K to 13.99K | |
26-Feb-20 4:31 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 24-Feb-20 | Payment of Exercise | 216 | $239.23 | $51,673.70 | (1%) 14.52K to 14.3K | |
07-Feb-20 4:10 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 05-Feb-20 | Grant | 12,421 | -- | -- | 592% 2.1K to 14.52K |